TP53 and neoplasm: The systemic delivery of several nano-platforms, based on natural lipids, polymers, or β-cyclodextrins, encapsulating wild-type p53, was shown to sensitize tumor cells, increase apoptosis, and reduce the tumor volume in mice [44,45,46].